Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 9, Pages -Publisher
MDPI
DOI: 10.3390/ijms23094501
Keywords
retinopathy; inflammation; pro-resolving mediators; lipoxins; resolvins; protectins; maresins; annexins; galectins
Funding
- ITALIAN MINISTRY OF EDUCATION
- UNIVERSITY AND RESEARCH [PRIN-2017TSHBXZ]
- CNCS/CCCDI-UEFISCDI [PN-III-P4-ID-PCE-2020-1772]
Ask authors/readers for more resources
This article discusses the importance of resolution of inflammation in preventing the progression of retinal damage and highlights the role of pro-resolving mediators in modulating inflammatory exudates, as well as potential drug targets in the treatment of retinal diseases.
The most frequent retinal diseases, such as diabetic retinopathy, age-related macular degeneration and posterior uveitis, are underlined by oxidative stress or aging-induced retinal inflammation, which contributes to vision impairing or loss. Resolution of inflammation is emerging as a critical phase able to counteract the inflammatory process leading to the progression of retinal damage. Particularly, pro-resolving mediators (PMs) play a key role in the modulation of inflammatory exudates and could be considered a new target to be investigated in different inflammatory-autoimmune pathologies. Here, we highlight the most recent studies concerning the role of the main PMs (lipoxins, resolvins, prtectins, maresins and annexins) in retinal inflammation, in order to collect the best evidence in the field of inflammatory retinal damage resolution and to propose novel pharmacological approaches in the management of the most common retinal diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available